Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takehiro Hashimoto

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Emerging Infectious Diseases|April 27, 2017
Importation of Zika Virus from Vietnam to Japan, November 2016Takehiro Hashimoto, Satoshi Kutsuna, Shigeru Tajima, et al.
International Journal of Molecular Sciences|December 17, 2024
Exploring the Replication and Pathogenic Characteristics of Alpha, Delta, and Omicron Variants of SARS-CoV-2Sakirul Khan, Takaaki Yahiro, Kazunori Kimitsuki, et al.
Microbiology Spectrum|April 9, 2025
Multiplex PCR assay to identify clinically important <i>Aeromonas</i> speciesAki Sakurai, Naoto Hosokawa, Daisuke Ohkushi, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|October 15, 2018
Real-time PCR investigation of the prevalence of Fusobacterium necrophorum in patients with pharyngitis in JapanKayoko Hayakawa, Maki Nagashima, Eriko Kanehisa, et al.
Environmental Pollution (Barking, Essex : 1987)|January 30, 2026
Ambient PM<sub>2</sub>.<sub>5</sub> exposure and increased dengue case fatality: a global multi-country analysisSakirul Khan, Najmul Haider, Takaaki Yahiro, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|January 8, 2026
In vitro activity of cefiderocol against carbapenem-resistant Gram-negative pathogens in JapanKenjiro Matsui, Aki Sakurai, Yasufumi Matsumura, et al.
Scientific Reports|May 23, 2026
Carbapenem-resistant Gram-negative bacilli infections in Japanese patients with cancerNaoya Itoh, Takanori Kawabata, Nana Akazawa, et al.
Antimicrobial Agents and Chemotherapy|September 13, 2023
Effectiveness of cefmetazole versus meropenem for invasive urinary tract infections caused by extended-spectrum β-lactamase-producing <i>Escherichia coli</i>Kayoko Hayakawa, Yasufumi Matsumura, Kohei Uemura, et al.
Genome Research|January 7, 2010
Cross-mapping and the identification of editing sites in mature microRNAs in high-throughput sequencing librariesMichiel J L de Hoon, Ryan J Taft, Takehiro Hashimoto, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|June 15, 2024
Comparison of the effects of cefmetazole and meropenem on microbiome: A pilot studyKayoko Hayakawa, Sho Saito, Tohru Miyoshi-Akiyama, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Emerging Infectious Diseases|April 27, 2017
Importation of Zika Virus from Vietnam to Japan, November 2016Takehiro Hashimoto, Satoshi Kutsuna, Shigeru Tajima, et al.
International Journal of Molecular Sciences|December 17, 2024
Exploring the Replication and Pathogenic Characteristics of Alpha, Delta, and Omicron Variants of SARS-CoV-2Sakirul Khan, Takaaki Yahiro, Kazunori Kimitsuki, et al.
Microbiology Spectrum|April 9, 2025
Multiplex PCR assay to identify clinically important <i>Aeromonas</i> speciesAki Sakurai, Naoto Hosokawa, Daisuke Ohkushi, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|October 15, 2018
Real-time PCR investigation of the prevalence of Fusobacterium necrophorum in patients with pharyngitis in JapanKayoko Hayakawa, Maki Nagashima, Eriko Kanehisa, et al.
Environmental Pollution (Barking, Essex : 1987)|January 30, 2026
Ambient PM<sub>2</sub>.<sub>5</sub> exposure and increased dengue case fatality: a global multi-country analysisSakirul Khan, Najmul Haider, Takaaki Yahiro, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|January 8, 2026
In vitro activity of cefiderocol against carbapenem-resistant Gram-negative pathogens in JapanKenjiro Matsui, Aki Sakurai, Yasufumi Matsumura, et al.
Scientific Reports|May 23, 2026
Carbapenem-resistant Gram-negative bacilli infections in Japanese patients with cancerNaoya Itoh, Takanori Kawabata, Nana Akazawa, et al.
Antimicrobial Agents and Chemotherapy|September 13, 2023
Effectiveness of cefmetazole versus meropenem for invasive urinary tract infections caused by extended-spectrum β-lactamase-producing <i>Escherichia coli</i>Kayoko Hayakawa, Yasufumi Matsumura, Kohei Uemura, et al.
Genome Research|January 7, 2010
Cross-mapping and the identification of editing sites in mature microRNAs in high-throughput sequencing librariesMichiel J L de Hoon, Ryan J Taft, Takehiro Hashimoto, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|June 15, 2024
Comparison of the effects of cefmetazole and meropenem on microbiome: A pilot studyKayoko Hayakawa, Sho Saito, Tohru Miyoshi-Akiyama, et al.
Pageof 7